Every trade. Every test. Nothing hidden.
A five-year backtest of the four-engine stack, the same strategy now running as a live forward test, paper-traded in public, measured the way a quant desk measures itself: on risk-adjusted return first, then statistical significance, the drawdown record, and the full 403-trade ledger you can download and check. The stack now trims 40% of a position once it has been held 15 trading days and lets the rest run, a refinement that lifted the Sharpe to 2.44 by smoothing the ride rather than reaching for more return.
Read the headline honestly: 64% of the backtest’s dollar return came from just 10 of its 403 trades. In a book that compounds, that makes the CAGR the least repeatable number here, the durable claim is the +13.3% average per-trade expectancy, which stays positive (+10.0% per trade) even with those ten largest winners removed, not the +137.2% headline rate.
The day-15 trim the live stack now runs is part of that same honesty. It raised the Sharpe from 1.78 to 2.44 by clipping the most violent up-days, and its per-year Sharpe is higher in every regime in the table below. The extra NAV it shows over the prior model is concentrated in 2024 and partly given back in 2025, so we treat the smoother ride, not a higher return, as the durable gain. The prior model stays on the record, see how the strategy evolved.
One book, four guardians
A single total-NAV track from $100k, with the area beneath coloured by which guardian the regime classifier had deployed each day. Log scale, so the early years aren't crushed by the late compounding.
Each guardian is one engine in the stack, a distinct strategy the regime classifier deploys when conditions favour it. The colours match the curve above, the per-guardian breakdown, and the 403-trade ledger below, so every figure on this page traces back to one of these four.
Small-cap quality composite. Fires when the macro regime favours durable margins and conservative leverage.
Small-cap aggressive momentum breakouts. The workhorse in trending and choppy markets.
Defensive sectors and commodities. Active when the broad market is weak.
Large-cap speculative recovery. Active during macro transitions out of defensive regimes.
Is the edge real, or just luck?
The hard question for any backtest. We answer it the way the literature demands, with confidence intervals, a multiple-testing-aware t-statistic, and a Deflated Sharpe Ratio that penalises for every configuration we tried.
The t-statistic of 5.45 is the one to anchor on. Harvey, Liu & Zhu (2016) argue that because researchers test thousands of strategies, the usual t > 2 bar is far too lax, a genuine finding should clear roughly |t| > 3. This backtest does, on 1,257 daily returns (from 1,258 daily NAV marks, returns are n−1). The Probabilistic Sharpe Ratio, the probability the true Sharpe is above zero, correcting for the return series being non-normal, is > 99.9%.
The strongest test is the Deflated Sharpe Ratio. During research we ran 242 distinct strategy configurations; the more you try, the higher a Sharpe you should expect to find by chance alone. The expected best-of-242 under the null is only 0.756. The realised 2.44 sits far above it, so the deflated probability the edge is real is still > 99.9%. The edge is not an artefact of the search.
One honest caveat the numbers make plain: the daily returns are highly non-normal, positively skewed (skew 5.8) with fat tails (excess kurtosis 46) and a high 38% annualised volatility. That is the nature of a concentrated small-cap momentum book: the volatility is dominated by upside, the occasional explosive winner, while the downside stays contained, which is exactly why the worst drawdown is only 16%. We report the Probabilistic and Deflated Sharpe precisely because they correct for that non-normality, where the raw Sharpe assumes it away. The same asymmetry inflates any ratio that sees only the downside: a Calmar of 8.61 (CAGR ÷ max drawdown) would read impressively, which is exactly why we don’t headline it. It is arithmetically real but flattered by the same asymmetry, the volatility is almost all upside, so the drawdown denominator stays small while the return numerator runs. Read it as a drawdown-efficiency note, not a figure that out-classes the 2.44 Sharpe.
A practical note for anyone reconciling the three headline figures: they will not tie out under the textbook identity, and that is expected. The arithmetic mean return is ≈94%/yr (Sharpe 2.44 × 38% volatility). The usual variance-drag shortcut, geometric ≈ arithmetic − ½σ², would then put the compound return near 86%, yet the realised CAGR is 137.2%. That identity assumes roughly normal returns; at skew 5.8 and excess kurtosis 46 it does not hold here, the variance is overwhelmingly upside variance that compounds in the book’s favour rather than dragging, so the geometric return lands above the Gaussian prediction, not below. The figures are internally consistent; it is the normal-distribution shortcut linking them that breaks.
The Sharpe ratio measured over every trailing one-year window, a test of consistency, not a single end-point number.
Skill, or just the tape?
2024 to 25 was a strong run for small-caps, so the fair question is whether this is alpha or market beta. Measured against the three major US benchmarks below, the strategy's beta is statistically indistinguishable from zero, the return is not benchmark exposure.
| Index | Return · 5y | CAGR | β · all/dep | R² | Ann. α (t) |
|---|---|---|---|---|---|
| Shishin | +7,441% | +137% | – | – | – |
| S&P 500 SPY | +85% | +13% | -0.05 · -0.01 | 0.001 | +156% (5.49) |
| Russell 2000 IWM | +34% | +6% | -0.06 · -0.01 | 0.001 | +156% (5.48) |
| Nasdaq 100 QQQ | +127% | +18% | -0.05 · -0.01 | 0.001 | +157% (5.50) |
The honest, defensible read is the R²: ≈ 0 against all three, the market explains almost none of the stack’s daily variance. The all-days beta (~0) is partly mechanical, a third of days are in cash, where the daily return is zero, which pulls beta toward zero regardless of skill, but the deployed-day beta is also near zero (the second figure in the β column), so it isn’t merely a cash artifact: even when invested, the book is uncorrelated with the index. We’d rather make the weaker, sturdier claim, the market explains almost none of our variance, than “market-neutral by design.” And the benchmark that should most flatter a small-cap momentum book, the Russell 2000, compounded at just 6% over the window, against the stack’s 137.2%. So this is not the small-cap index’s return, whether it is small-cap momentum (naive winners-chasing, levered up) is the harder question the factor check below begins, but does not finish, probing.
Stripping market exposure (CAPM, risk-free ≈ 0), Jensen’s alpha is ≈ +156%/yr at a t-stat of 5.49, it clears the same |t| > 3 bar. With beta at zero the alpha is, in effect, the entire return; it lands above the 137.2% geometric CAGR for the same arithmetic-vs-geometric reason noted above.
We also ran the Treynor-Mazuy timing test, regressing the stack’s return on the market return and its square, where a positive γ would signal market-timing convexity. Across all three benchmarks γ is not statistically significant (|t| < 1.5). That is what you’d expect when beta is already ≈ 0: there is little market exposure to time. The regime switch surfaces as the near-zero beta and the large alpha, not as a timing coefficient, the edge here is selection, not market timing, and we don’t claim otherwise. (In-sample, no Newey-West autocorrelation adjustment, so treat the alpha t-stat as an upper bound.)
SPY / IWM / QQQ are the factors least likely to explain a momentum book. The real tests are the momentum factor itself and a risk-on / speculative-growth factor, so we regress the daily return on all of them at once (ETF proxies, rf ≈ 0).
| Factor (ETF proxy) | Loading β | t-stat |
|---|---|---|
| Market (SPY) | -0.02 | -0.26 |
| Size (IWM−SPY) | -0.15 | -1.16 |
| Value (IWD−IWF) | +0.11 | 0.87 |
| Momentum (MTUM−SPY) | -0.16 | -1.45 |
| Spec. growth (ARKK−SPY) | +0.04 | 0.78 |
| Alpha (annualised) | +157% | 5.48 |
Against this set the alpha is ≈ +157%/yr at t 5.48 (R² 0.4%), but read that as a first-pass screen, not exoneration. The momentum factor here (MTUM) is slow, large-cap, 12-minus-1-month; this book holds micro-caps for roughly twelve days, so its low loading (-0.16) means “our momentum is faster and smaller than the factor,” not “no momentum exposure”, only a high loading would have been damning. And a daily regression on a high-volatility, one-third-cash book is largely swamped by idiosyncratic variance, so a near-zero R² across every factor is as much a power limitation as a sign of alpha.
So treat this as a screen, not a verdict. The test that actually separates “naive small-cap momentum, levered” from genuine selection, a short-horizon winners-minus-losers built on our own universe, is the next panel, and it’s the one that matters.
ETF-proxy Carhart factors; ARKK (innovation) stands in for the crypto/BTC risk-on factor, which is not in the dataset. rf≈0, in-sample, no Newey–West.
The question a factor model can’t answer: does the stack beat naive small-cap momentum, or just lever it? French’s UMD can’t tell us, it’s slow and large-cap. So we built a winners-minus-losers factor on our own survivorship-free universe at our own horizon: top-minus-bottom quintile of 21-day return, rebalanced weekly, ~628 names a side.
| Shishin ~ own WML | β (t) | Alpha/yr (t) | R² |
|---|---|---|---|
| Daily | -0.16 (-1.93) | +150% (3.84) | 0.003 |
| Weekly | -0.32 (-1.25) | +159% (3.21) | 0.006 |
| Deployed | -0.01 (-0.17) | +118% (2.98) | 0.000 |
Two things settle it. First, naive small-cap momentum was flat over this window, the factor’s Sharpe was 0.05 (+0.9%/yr, compounded -4%), so there is no premium to lever. Second, the stack doesn’t even load on it: its beta is near zero to slightly negative at every frequency (table), while the alpha holds. Crucially, running it weekly and deployed-only, to escape the daily idiosyncratic-variance swamp , keeps the alpha significant (t 3.21 and 2.98) with the momentum beta still ~0. So it is not the momentum premium scaled up, there was none to scale.
The honest limit, and it is the same across every regression on this page: the R² is ≈ 0, CAPM (0.001), Carhart (0.4%), and this own-universe WML (0.00 to 0.01) alike. That cuts both ways. No market, size, value or momentum factor explains the book’s daily variance, so “alpha survives” is partly just “these factors explain almost nothing”, exactly what a concentrated, idiosyncratic stock-picking book looks like. But it also means a factor regression is a low-power test here, not a proof of skill. What is clean: there was no momentum premium to lever, the book carries ~no factor beta, and the large residual is significant on its own (t > 3). What broad factors can’t isolate is the per-name concentration, the crypto-miner / quantum / precious-metal cluster, which the panel below measures head-on.
Equal-weight top-minus-bottom quintile of trailing 21-day return (skip 1) on the survivorship-free equity universe, liquidity-screened, rebalanced weekly. Point-in-time via bar availability. rf≈0, in-sample, no Newey–West.
The biggest winners cluster in three themes no broad factor measures, crypto miners, precious-metal miners, and quantum / spec-tech. We built each as an equal-weight basket from our own universe and regressed the book on all three at once. This is the regression that should bite.
| Theme basket | Names | Return/yr | Sharpe |
|---|---|---|---|
| Crypto miners | 17 | +58% | 0.70 |
| Precious-metal miners | 17 | +32% | 0.75 |
| Quantum / spec-tech | 8 | +79% | 0.90 |
Two honest readings. The themes were real but only modestly profitable, Sharpe 0.70-0.90, well below the stack’s 2.44, so even full exposure wouldn’t reach 137.2%. And the book barely loads on them: jointly, R² is only 0.031 (daily), beta to crypto and precious-metals ≈ 0, and the alpha is +168%/yr (t 4.19), still significant weekly (t 3.50) and deployed (t 3.11). The one significant loading, quantum, -0.11 (t -6.16), is negative: a timing artifact, because the book holds quantum names only episodically (when the regime + breakout gate fire), so its returns don’t co-move with a continuously-held basket. That is exactly the point, the edge is which names, and when.
So across CAPM, Carhart, own-universe momentum, and now the concentration themes, no factor or basket explains the book’s variance: the return is concentrated, timed, idiosyncratic selection. That is consistent with skill, but a backtest regression cannot prove skill, and we won’t claim it does. The honest final word is the forward, live paper-traded track on the dashboard.
Equal-weight, daily-rebalanced long-only baskets of the book's concentration themes, built from its own universe (point-in-time via bar availability). Joint regression rp = a + b1*crypto + b2*pmminer + b3*quantum. rf≈0, in-sample, no Newey–West.
The edge holds across regimes
The most damning thing for a strategy is to make all its money in one lucky year. This one was positive every calendar year, including the 2022 bear, when it was one of its strongest.
| Year | Regime | Return | Sharpe | t-stat | Days |
|---|---|---|---|---|---|
| 2021 ·part | Partial · launch | -1.7% | -0.12 | -0.10 | 163 |
| 2022 | Bear | +69.7% | 2.56 | 2.56 | 251 |
| 2023 | Recovery | +50.9% | 1.92 | 1.91 | 250 |
| 2024 | Broadening | +397.4% | 3.13 | 3.13 | 252 |
| 2025 | Bull | +294.1% | 3.20 | 3.19 | 250 |
| 2026 ·part | Partial · YTD | +52.8% | 2.56 | 1.55 | 92 |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | ||||||||||||
| 2022 | 15 | 16 | 14 | |||||||||
| 2023 | 31 | 12 | ||||||||||
| 2024 | 23 | 37 | 10 | 80 | 16 | 56 | ||||||
| 2025 | 49 | 28 | 15 | 31 | 21 | 11 | ||||||
| 2026 | 49 |
What it cost to ride it
The five deepest peak-to-trough declines. Every one recovered. A Monte-Carlo bootstrap says the realised 16% worst case was, if anything, mild, 66.8% of resampled paths drew down deeper.
| Depth | Peak | Trough | Recovered | Decline | Recovery |
|---|---|---|---|---|---|
| -15.9% | 2024-03-13 | 2024-05-22 | 2024-08-15 | 49d | 58d |
| -15.2% | 2024-09-03 | 2024-11-14 | 2024-11-27 | 52d | 9d |
| -12.1% | 2021-06-14 | 2021-07-15 | 2022-04-01 | 22d | 181d |
| -11.2% | 2023-02-17 | 2023-05-15 | 2023-06-16 | 59d | 23d |
| -9.3% | 2024-01-02 | 2024-01-23 | 2024-02-13 | 14d | 15d |
One honest limitation: that bootstrap reshuffles return blocks, which keeps short-run autocorrelation but breaks the longer-range stop-loss sequencing that actually contained these drawdowns, so it structurally over-states plausible drawdown. Read the comparison as a sanity check that the realised 15.9% isn’t a freak low, not as proof the live path will be as shallow.
How the money was actually made
403 trades over 5.0 years. A 54.8% win rate that makes money because winners are 3.74× the size of losers, and stops, not hope, close the bad ones.
Note the bases differ: profit factor is dollar-weighted (gross winning dollars ÷ gross losing dollars, at Shishin’s position sizing), while the avg-win / avg-loss payoff of 3.74× is the equal-weighted per-trade percentage ratio. They are not meant to reconcile to the same figure.
STOP_LOSS is the initial protective stop, a loss by construction (0% win), so it is never where a profit is booked. Trades that run into profit are trailed out by MA12_CLOSE (a close back below the trend) and TIMED_EXIT, those are the profit-taking exits.
| STOP_LOSS | 144 | 0% win | -9.5% |
| MA12_CLOSE | 101 | 81.2% win | +27.4% |
| TIMED_EXIT | 89 | 87.6% win | +15.4% |
| DAY15_TRIM | 50 | 100% win | +50.6% |
| GATE_EXIT | 17 | 52.9% win | +2.7% |
| END_OF_BACKTEST | 2 | 100% win | +8.6% |
Each engine’s share of the 403 trades and the gains.
| Genbu | 51 tr | 45.1% win | $0.93M |
| Suzaku | 159 tr | 53.5% win | $5.24M |
| Byakko | 164 tr | 58.5% win | $0.50M |
| Seiryū | 29 tr | 58.6% win | $0.77M |
Is the edge just a handful of trades?
The fair question for a book this skewed (skew 5.8, excess kurtosis 46): did a few moonshots make the whole result? We delete the biggest winners and re-measure the AVERAGE remaining trade, two ways, because how you rank "biggest" matters.
The honest half first: the dollars are concentrated. Ranked by realized P&L, the top 5 trades are 45% of all gains and the top 10 are 64%, what a compounding book that sizes up as it grows looks like.
But ranking by dollars is confounded with timing: a book makes its biggest dollars when the account is biggest, so the largest-dollar trades are mostly the most recent ones (2024×3, 2025×8, 2026×4 among the fifteen biggest), an artifact of when, not a measure of the best picks. So we also rank scale-free, by percentage return, which scores a pick the same whether it made $30k early or $1m late; by that measure the biggest winners spread across the record (2023×1, 2024×11, 2025×3). The edge survives both: strip the ten biggest and the remaining 393 trades still clear the |t| > 3 bar, per-trade t 6.65 by dollars, 7.14 by percent.
| Top removed | Trades | $ share | Avg trade | Per-trade t |
|---|---|---|---|---|
| None | 403 | , | +13.3% | 6.50 |
| Top 1 | 402 | 18% | +12.9% | 6.42 |
| Top 3 | 400 | 35% | +12.2% | 6.23 |
| Top 5 | 398 | 45% | +11.3% | 6.39 |
| Top 10 | 393 | 64% | +10.0% | 6.65 |
| Top 20 | 383 | 89% | +8.8% | 5.93 |
| Top 30 | 373 | 105% | +7.8% | 5.52 |
| Top removed | Trades | $ share | Avg trade | Per-trade t |
|---|---|---|---|---|
| None | 403 | , | +13.3% | 6.50 |
| Top 1 | 402 | 4% | +12.4% | 6.77 |
| Top 3 | 400 | 10% | +10.9% | 7.21 |
| Top 5 | 398 | 30% | +10.0% | 7.25 |
| Top 10 | 393 | 48% | +8.3% | 7.14 |
| Top 20 | 383 | 61% | +6.1% | 6.38 |
| Top 30 | 373 | 74% | +4.5% | 5.38 |
Per-trade t = mean trade return ÷ its standard error (n−1), a different statistic from the daily-return t of 5.45 in the significance section; it isolates whether the typical trade, not the portfolio, carries the edge. Removing the single biggest %-winner even raises it (6.50 → 6.77): the moonshots are variance, not significance. The dollar ranking holds to ~the top 25 before significance fades; the percentage ranking is the harder test and fades sooner (~the top 15), which is exactly what a strategy built to catch big movers should do, since deleting every big mover deletes the edge by design. On the dollar ranking, the $ share tops 100% by the time the top twenty are gone, those removed trades exceed the entire dollar profit, so the trades left over lose money in aggregate; that their average % trade nonetheless stays positive and significant is the point (the dollars sit in the tail, the per-trade edge in the body). Either way the headline holds: it is not five trades, and it survives the ten biggest.
Now trim both tails
Removing only winners is the hard test, it deletes only the trades that help. The balanced one is a symmetric trim: remove the top-N winners AND the bottom-N losers, both ways we ranked them, and re-measure the middle.
Trim the top 10 and bottom 10 and the per-trade t barely moves: 6.85 by dollars, 7.58 by percent, against 6.50 untouched. Even ±20 holds above 3. The edge sits in the body of the distribution, not the tails. The twist: this fair test is actually kinder than removing winners alone, deleting the losers helps the mean, so these t’s run a touch above the winners-only ones above. The hard test is the conservative bound; this is the reassurance.
One asymmetry to be honest about: the two tails aren’t the same size. Stops cap the left one, the ten worst trades are nine at exactly −15% (the ATR stop) and one −18.5% gap, while the right tail is uncapped (the best is +355%). So “ten from each end” deletes far more magnitude from the winners’ side than the losers’, and the per-trade significance still barely moves. Cut losers small, let winners run, and the edge is broad enough to survive trimming both ends.
| Trimmed each end | Trades | Avg trade | Per-trade t |
|---|---|---|---|
| None | 403 | +13.3% | 6.50 |
| ±1 | 401 | +12.9% | 6.43 |
| ±3 | 397 | +12.4% | 6.27 |
| ±5 | 393 | +11.6% | 6.48 |
| ±10 | 383 | +10.5% | 6.85 |
| ±20 | 363 | +9.8% | 6.33 |
| Trimmed each end | Trades | Avg trade | Per-trade t |
|---|---|---|---|
| None | 403 | +13.3% | 6.50 |
| ±1 | 401 | +12.4% | 6.80 |
| ±3 | 397 | +11.1% | 7.31 |
| ±5 | 393 | +10.4% | 7.43 |
| ±10 | 383 | +9.0% | 7.58 |
| ±20 | 363 | +7.3% | 7.44 |
All 403 trades
Every realized exit the stack made, sortable and filterable, downloadable as CSV. The winners and the losers, not a highlight reel. A day-15 trim shows as its own row, so a trimmed position appears as two lots (the 40% scale-out plus the 60% final exit): 403 exits across 353 positions, 50 of them trimmed.
| Guardian | Symbol | Entry▲ | Days | P&L % | P&L $ | Size $ | Shishin Score | Exit |
|---|---|---|---|---|---|---|---|---|
| Genbu | UPSTDiversified Finan Serv | 2021-05-20 | 20 | +9.4% | +$1,802 | $19,212 | 66.4 | MA12_CLOSE |
| Genbu | UONEKMedia | 2021-05-21 | 3 | -9.3% | -$1,810 | $19,565 | 70.7 | STOP_LOSS |
| Genbu | PDSBBiotechnology | 2021-05-24 | 14 | +7.2% | +$1,281 | $17,754 | 69.1 | MA12_CLOSE |
| Genbu | SKINCosmetics/Personal Care | 2021-06-07 | 15 | +7.4% | +$1,409 | $19,032 | 72.0 | MA12_CLOSE |
| Genbu | AGENBiotechnology | 2021-06-09 | 15 | +8.2% | +$678 | $8,267 | 71.3 | DAY15_TRIM |
| Genbu | AGENBiotechnology | 2021-06-09 | 27 | +5.9% | +$734 | $12,450 | 71.3 | MA12_CLOSE |
| Genbu | BTUCoal | 2021-06-10 | 7 | -11.3% | -$2,400 | $21,170 | 73.7 | STOP_LOSS |
| Genbu | CLFIron/Steel | 2021-06-10 | 5 | -7.0% | -$1,483 | $21,144 | 73.8 | STOP_LOSS |
| Genbu | NTLABiotechnology | 2021-06-15 | 1 | -7.6% | -$1,482 | $19,611 | 72.0 | STOP_LOSS |
| Genbu | ASANSoftware | 2021-06-16 | 15 | +34.0% | +$2,464 | $7,236 | 62.5 | DAY15_TRIM |
| Genbu | ASANSoftware | 2021-06-16 | 30 | +31.0% | +$3,372 | $10,903 | 62.5 | MA12_CLOSE |
| Genbu | AVXLBiotechnology | 2021-06-21 | 1 | -9.5% | -$1,786 | $18,770 | 66.7 | STOP_LOSS |
| Genbu | ATOSBiotechnology | 2021-06-22 | 8 | -13.5% | -$2,492 | $18,446 | 72.9 | STOP_LOSS |
| Genbu | GSATTelecommunications | 2021-06-23 | 13 | -10.6% | -$1,964 | $18,471 | 74.1 | STOP_LOSS |
| Genbu | LIAuto Manufacturers | 2021-06-25 | 12 | +0.9% | +$178 | $19,756 | 70.3 | MA12_CLOSE |
| Genbu | NBPBiotechnology | 2021-06-30 | 6 | -8.8% | -$2,066 | $23,361 | 68.6 | STOP_LOSS |
| Genbu | ANVSBiotechnology | 2021-07-06 | 9 | -2.6% | -$416 | $16,287 | 74.1 | MA12_CLOSE |
| Genbu | FLNABiotechnology | 2021-07-06 | 9 | -9.9% | -$1,618 | $16,256 | 69.7 | STOP_LOSS |
| Genbu | BTUCoal | 2021-07-08 | 8 | -11.4% | -$2,655 | $23,263 | 76.2 | STOP_LOSS |
| Genbu | INMBBiotechnology | 2021-07-12 | 3 | -8.7% | -$2,031 | $23,253 | 74.0 | STOP_LOSS |
| Genbu | MRNABiotechnology | 2021-07-16 | 15 | +44.3% | +$3,150 | $7,168 | 66.8 | DAY15_TRIM |
| Genbu | MRNABiotechnology | 2021-07-16 | 26 | +34.3% | +$3,654 | $10,609 | 66.8 | MA12_CLOSE |
| Genbu | ASANSoftware | 2021-09-03 | 15 | +21.3% | +$1,588 | $7,422 | 73.9 | DAY15_TRIM |
| Genbu | ASANSoftware | 2021-09-03 | 25 | +8.7% | +$975 | $11,179 | 73.9 | MA12_CLOSE |
| Genbu | BTUCoal | 2021-09-08 | 7 | -8.5% | -$1,584 | $18,609 | 70.5 | STOP_LOSS |
| Genbu | AEHRSemiconductors | 2021-09-13 | 7 | -12.4% | -$2,259 | $18,161 | 70.6 | STOP_LOSS |
| Genbu | DOCNSoftware | 2021-09-15 | 13 | -3.9% | -$717 | $18,533 | 65.3 | MA12_CLOSE |
| Byakko | FHTXPharmaceuticals | 2021-12-14 | 11 | +23.8% | +$3,828 | $16,102 | 50.0 | TIMED_EXIT |
| Byakko | CENXMining | 2021-12-22 | 11 | +9.8% | +$1,661 | $17,039 | 50.0 | TIMED_EXIT |
| Byakko | SCNIPharmaceuticals | 2021-12-23 | 8 | -13.0% | -$2,073 | $15,925 | 50.0 | STOP_LOSS |
| Byakko | XOPDefensive ETF | 2022-02-01 | 13 | -2.4% | -$583 | $24,442 | 0.0 | GATE_EXIT |
| Byakko | SENSPharmaceuticals | 2022-02-03 | 7 | -9.4% | -$1,583 | $16,907 | 50.0 | STOP_LOSS |
| Byakko | MDGLPharmaceuticals | 2022-02-08 | 11 | +11.9% | +$1,902 | $16,042 | 50.0 | TIMED_EXIT |
| Byakko | HAEHealthcare-Products | 2022-02-09 | 11 | +3.5% | +$579 | $16,568 | 50.0 | TIMED_EXIT |
| Byakko | PFGCFood | 2022-02-09 | 11 | +7.4% | +$1,242 | $16,692 | 50.0 | TIMED_EXIT |
| Byakko | GSMMining | 2022-02-10 | 11 | +25.5% | +$1,858 | $7,285 | 50.0 | TIMED_EXIT |
| Byakko | GDXDefensive ETF | 2022-02-16 | 15 | +16.1% | +$983 | $6,136 | 0.0 | DAY15_TRIM |
| Byakko | GDXDefensive ETF | 2022-02-16 | 44 | +13.6% | +$1,250 | $9,187 | 0.0 | GATE_EXIT |
| Byakko | AVNSHealthcare-Products | 2022-02-25 | 8 | -5.1% | -$875 | $17,204 | 50.0 | STOP_LOSS |
| Byakko | CELHBeverages | 2022-02-25 | 6 | -9.4% | -$1,744 | $18,572 | 50.0 | STOP_LOSS |
| Byakko | LFSTHealthcare-Services | 2022-02-25 | 1 | -9.8% | -$1,721 | $17,546 | 50.0 | STOP_LOSS |
| Byakko | SGRYHealthcare-Services | 2022-02-25 | 11 | +8.8% | +$648 | $7,348 | 50.0 | TIMED_EXIT |
| Byakko | XOPDefensive ETF | 2022-02-25 | 15 | +12.7% | +$1,288 | $10,107 | 0.0 | DAY15_TRIM |
| Byakko | XOPDefensive ETF | 2022-02-25 | 39 | +20.0% | +$3,036 | $15,217 | 0.0 | GATE_EXIT |
| Byakko | ALHCHealthcare-Services | 2022-03-07 | 6 | -9.5% | -$1,599 | $16,818 | 50.0 | STOP_LOSS |
| Byakko | OISOil&Gas Services | 2022-03-08 | 2 | -8.6% | -$1,493 | $17,452 | 50.0 | STOP_LOSS |
| Byakko | CLOVHealthcare-Services | 2022-03-09 | 4 | -11.9% | -$2,163 | $18,219 | 50.0 | STOP_LOSS |
| Byakko | XLEDefensive ETF | 2022-03-14 | 15 | +3.5% | +$327 | $9,319 | 0.0 | DAY15_TRIM |
| Byakko | XLEDefensive ETF | 2022-03-14 | 224 | +15.6% | +$2,178 | $14,015 | 0.0 | GATE_EXIT |
| Byakko | CLOVHealthcare-Services | 2022-03-16 | 11 | +24.6% | +$4,005 | $16,300 | 50.0 | TIMED_EXIT |
| Byakko | LFSTHealthcare-Services | 2022-03-16 | 11 | +10.8% | +$1,803 | $16,762 | 50.0 | TIMED_EXIT |
| Byakko | AGLHealthcare-Services | 2022-03-17 | 11 | +28.0% | +$555 | $1,980 | 50.0 | TIMED_EXIT |
| Byakko | CELHBeverages | 2022-03-18 | 11 | +3.9% | +$461 | $11,894 | 50.0 | TIMED_EXIT |
| Byakko | TMCMining | 2022-03-30 | 11 | +17.3% | +$2,854 | $16,519 | 50.0 | TIMED_EXIT |
| Byakko | DRTSHealthcare-Products | 2022-04-05 | 5 | -15.0% | -$2,428 | $16,189 | 50.0 | STOP_LOSS |
| Byakko | CDEMining | 2022-04-13 | 6 | -6.7% | -$1,077 | $16,150 | 50.0 | STOP_LOSS |
| Byakko | LIXTHealthcare-Products | 2022-04-13 | 2 | -15.0% | -$2,418 | $16,119 | 50.0 | STOP_LOSS |
| Byakko | OGIPharmaceuticals | 2022-04-13 | 6 | -8.2% | -$1,352 | $16,512 | 50.0 | STOP_LOSS |
| Byakko | AGIGOil&Gas | 2022-04-18 | 4 | -15.0% | -$2,309 | $15,392 | 50.0 | STOP_LOSS |
| Byakko | USEGOil&Gas | 2022-04-18 | 6 | -14.6% | -$1,952 | $13,390 | 50.0 | STOP_LOSS |
| Byakko | WTIOil&Gas | 2022-05-04 | 11 | +10.6% | +$1,387 | $13,071 | 50.0 | TIMED_EXIT |
| Byakko | XOPDefensive ETF | 2022-05-04 | 3 | -11.5% | -$2,797 | $24,301 | 0.0 | GATE_EXIT |
| Byakko | AHCOPharmaceuticals | 2022-05-13 | 11 | +14.5% | +$1,918 | $13,199 | 50.0 | TIMED_EXIT |
| Byakko | DDLFood | 2022-05-16 | 6 | -15.0% | -$1,929 | $12,859 | 50.0 | STOP_LOSS |
| Byakko | SNOAPharmaceuticals | 2022-05-16 | 11 | +0.6% | +$80 | $13,720 | 50.0 | TIMED_EXIT |
| Byakko | XOPDefensive ETF | 2022-05-17 | 15 | +19.2% | +$1,817 | $9,424 | 0.0 | DAY15_TRIM |
| Byakko | XOPDefensive ETF | 2022-05-17 | 19 | +7.6% | +$1,082 | $14,207 | 0.0 | GATE_EXIT |
| Byakko | MNKDPharmaceuticals | 2022-05-20 | 11 | +22.3% | +$3,004 | $13,497 | 50.0 | TIMED_EXIT |
| Byakko | GYREPharmaceuticals | 2022-05-24 | 11 | +27.6% | +$3,557 | $12,881 | 50.0 | TIMED_EXIT |
| Byakko | RRCOil&Gas | 2022-05-26 | 11 | +5.2% | +$162 | $3,144 | 50.0 | TIMED_EXIT |
| Byakko | APYXHealthcare-Products | 2022-05-27 | 11 | +14.6% | +$2,104 | $14,460 | 50.0 | TIMED_EXIT |
| Byakko | NTRAHealthcare-Products | 2022-05-27 | 3 | -9.6% | -$65 | $674 | 50.0 | STOP_LOSS |
| Byakko | DNAHealthcare-Services | 2022-06-03 | 6 | -12.0% | -$1,692 | $14,102 | 50.0 | STOP_LOSS |
| Byakko | AMLXPharmaceuticals | 2022-06-06 | 11 | +50.7% | +$6,870 | $13,559 | 50.0 | TIMED_EXIT |
| Byakko | OCGNPharmaceuticals | 2022-06-23 | 11 | +32.5% | +$4,343 | $13,373 | 50.0 | TIMED_EXIT |
| Byakko | TWSTHealthcare-Products | 2022-06-23 | 11 | +26.8% | +$3,818 | $14,274 | 50.0 | TIMED_EXIT |
| Byakko | ADPTHealthcare-Products | 2022-06-24 | 4 | -10.3% | -$1,393 | $13,452 | 50.0 | STOP_LOSS |
| Byakko | CELHBeverages | 2022-06-24 | 11 | +15.4% | +$2,128 | $13,797 | 50.0 | TIMED_EXIT |
| Byakko | HCMPharmaceuticals | 2022-06-24 | 11 | +16.7% | +$2,331 | $13,929 | 50.0 | TIMED_EXIT |
| Byakko | NTRAHealthcare-Products | 2022-06-24 | 5 | -8.8% | -$1,266 | $14,376 | 50.0 | STOP_LOSS |
| Byakko | AGIOPharmaceuticals | 2022-06-27 | 11 | +7.8% | +$1,016 | $13,035 | 50.0 | TIMED_EXIT |
| Byakko | PMVPPharmaceuticals | 2022-06-28 | 11 | +15.8% | +$423 | $2,681 | 50.0 | TIMED_EXIT |
| Byakko | ENTAPharmaceuticals | 2022-07-05 | 11 | +3.4% | +$455 | $13,511 | 50.0 | TIMED_EXIT |
| Byakko | GHHealthcare-Products | 2022-07-05 | 11 | +6.4% | +$742 | $11,655 | 50.0 | TIMED_EXIT |
| Byakko | PTGXPharmaceuticals | 2022-07-08 | 11 | +17.0% | +$2,311 | $13,578 | 50.0 | TIMED_EXIT |
| Byakko | VETOil&Gas | 2022-07-19 | 11 | +16.6% | +$2,130 | $12,834 | 50.0 | TIMED_EXIT |
| Byakko | UUUUMining | 2022-07-28 | 11 | +8.9% | +$1,156 | $12,999 | 50.0 | TIMED_EXIT |
| Byakko | AMRCElectric | 2022-07-29 | 11 | +28.1% | +$3,686 | $13,118 | 50.0 | TIMED_EXIT |
| Byakko | FTIOil&Gas Services | 2022-07-29 | 11 | +21.7% | +$2,749 | $12,660 | 50.0 | TIMED_EXIT |
| Byakko | HLXOil&Gas Services | 2022-07-29 | 11 | +9.0% | +$1,118 | $12,393 | 50.0 | TIMED_EXIT |
| Byakko | XOPDefensive ETF | 2022-07-29 | 15 | +4.1% | +$523 | $12,743 | 0.0 | DAY15_TRIM |
| Byakko | XOPDefensive ETF | 2022-07-29 | 24 | +1.5% | +$294 | $19,183 | 0.0 | GATE_EXIT |
| Byakko | PACBHealthcare-Products | 2022-08-03 | 11 | +54.4% | +$6,652 | $12,236 | 50.0 | TIMED_EXIT |
| Byakko | NERVPharmaceuticals | 2022-08-05 | 4 | -15.0% | -$1,922 | $12,812 | 50.0 | STOP_LOSS |
| Byakko | GDRXPharmaceuticals | 2022-08-08 | 8 | -8.6% | -$669 | $7,818 | 50.0 | STOP_LOSS |
| Byakko | WTIOil&Gas | 2022-08-10 | 11 | +25.7% | +$2,796 | $10,889 | 50.0 | TIMED_EXIT |
| Byakko | ELVNPharmaceuticals | 2022-09-08 | 11 | +17.2% | +$2,373 | $13,820 | 50.0 | TIMED_EXIT |
| Byakko | PACBHealthcare-Products | 2022-09-08 | 11 | -6.4% | -$795 | $12,415 | 50.0 | TIMED_EXIT |
| Byakko | AMLXPharmaceuticals | 2022-09-09 | 11 | +1.7% | +$228 | $13,289 | 50.0 | TIMED_EXIT |
| Byakko | BHCPharmaceuticals | 2022-09-12 | 11 | -0.5% | -$69 | $12,642 | 50.0 | TIMED_EXIT |
| Byakko | BEATHealthcare-Products | 2022-09-16 | 2 | -13.2% | -$1,631 | $12,365 | 50.0 | STOP_LOSS |
| Byakko | LYELPharmaceuticals | 2022-09-28 | 11 | -1.0% | -$127 | $12,685 | 50.0 | TIMED_EXIT |
| Byakko | CDEMining | 2022-09-29 | 11 | +11.7% | +$1,575 | $13,498 | 50.0 | TIMED_EXIT |
| Byakko | AGMining | 2022-10-03 | 11 | -2.5% | -$317 | $12,680 | 50.0 | TIMED_EXIT |
| Byakko | FSMMining | 2022-10-03 | 11 | +1.5% | +$194 | $12,769 | 50.0 | TIMED_EXIT |
| Byakko | EQXMining | 2022-10-04 | 3 | -7.5% | -$978 | $13,119 | 50.0 | STOP_LOSS |
| Byakko | EXKMining | 2022-10-04 | 5 | -7.4% | -$964 | $13,050 | 50.0 | STOP_LOSS |
| Byakko | HLMining | 2022-10-04 | 11 | +1.6% | +$195 | $12,236 | 50.0 | TIMED_EXIT |
| Byakko | PROil&Gas | 2022-10-04 | 11 | +15.3% | +$1,849 | $12,129 | 50.0 | TIMED_EXIT |
| Byakko | EGYOil&Gas | 2022-10-05 | 5 | -7.2% | -$895 | $12,386 | 50.0 | STOP_LOSS |
| Byakko | FNUCMining | 2022-10-05 | 5 | -15.0% | -$2,004 | $13,358 | 50.0 | STOP_LOSS |
| Byakko | GTEOil&Gas | 2022-10-05 | 11 | -0.7% | -$34 | $4,536 | 50.0 | TIMED_EXIT |
| Byakko | XOPDefensive ETF | 2022-10-07 | 15 | +4.7% | +$227 | $4,848 | 0.0 | DAY15_TRIM |
| Byakko | XOPDefensive ETF | 2022-10-07 | 23 | +4.3% | +$313 | $7,272 | 0.0 | GATE_EXIT |
| Byakko | PACBHealthcare-Products | 2022-10-13 | 11 | +27.2% | +$3,393 | $12,476 | 50.0 | TIMED_EXIT |
| Byakko | KPRXPharmaceuticals | 2022-10-19 | 2 | -15.0% | -$1,841 | $12,271 | 50.0 | STOP_LOSS |
| Byakko | SAMBeverages | 2022-10-24 | 4 | -6.1% | -$712 | $11,752 | 50.0 | STOP_LOSS |
| Byakko | PCVXPharmaceuticals | 2022-10-25 | 11 | +34.2% | +$4,450 | $13,022 | 50.0 | TIMED_EXIT |
| Byakko | BNGOHealthcare-Products | 2022-10-26 | 11 | -9.7% | -$1,242 | $12,798 | 50.0 | TIMED_EXIT |
| Byakko | CDNAHealthcare-Products | 2022-10-26 | 8 | -7.7% | -$924 | $11,933 | 50.0 | STOP_LOSS |
| Byakko | TLRYPharmaceuticals | 2022-10-26 | 11 | +3.7% | +$456 | $12,250 | 50.0 | TIMED_EXIT |
| Byakko | CYHHealthcare-Services | 2022-10-28 | 11 | +16.7% | +$2,081 | $12,441 | 50.0 | TIMED_EXIT |
| Byakko | BNGOHealthcare-Products | 2022-10-31 | 11 | +20.8% | +$2,304 | $11,088 | 50.0 | TIMED_EXIT |
| Byakko | FNUCMining | 2022-10-31 | 11 | +39.4% | +$4,800 | $12,189 | 50.0 | TIMED_EXIT |
| Byakko | HRMYPharmaceuticals | 2022-11-02 | 4 | -5.1% | -$610 | $11,906 | 50.0 | STOP_LOSS |
| Byakko | ACBPharmaceuticals | 2022-11-11 | 11 | -5.3% | -$686 | $12,838 | 50.0 | TIMED_EXIT |
| Byakko | ARVNPharmaceuticals | 2022-11-11 | 8 | -9.6% | -$1,163 | $12,121 | 50.0 | STOP_LOSS |
| Byakko | AZTAHealthcare-Products | 2022-11-11 | 11 | +22.5% | +$2,700 | $12,026 | 50.0 | TIMED_EXIT |
| Byakko | BLFSHealthcare-Products | 2022-11-11 | 5 | -11.6% | -$1,429 | $12,305 | 50.0 | STOP_LOSS |
| Byakko | INMDHealthcare-Products | 2022-11-11 | 11 | +1.5% | +$191 | $12,836 | 50.0 | TIMED_EXIT |
| Byakko | NEOGHealthcare-Products | 2022-11-11 | 11 | -3.9% | -$462 | $11,998 | 50.0 | TIMED_EXIT |
| Byakko | OMHealthcare-Products | 2022-11-11 | 11 | +4.0% | +$486 | $12,217 | 50.0 | TIMED_EXIT |
| Byakko | SGRYHealthcare-Services | 2022-11-11 | 5 | -9.7% | -$1,279 | $13,131 | 50.0 | STOP_LOSS |
| Byakko | SNDLFood | 2022-11-11 | 11 | +5.9% | +$714 | $12,145 | 50.0 | TIMED_EXIT |
| Byakko | TDOCHealthcare-Services | 2022-11-11 | 6 | -7.6% | -$124 | $1,642 | 50.0 | STOP_LOSS |
| Byakko | ESTAHealthcare-Products | 2022-11-14 | 11 | +1.5% | +$185 | $12,652 | 50.0 | TIMED_EXIT |
| Byakko | SHCHealthcare-Services | 2022-11-22 | 11 | +4.5% | +$562 | $12,449 | 50.0 | TIMED_EXIT |
| Byakko | SGRYHealthcare-Services | 2022-11-25 | 11 | -7.8% | -$929 | $11,958 | 50.0 | TIMED_EXIT |
| Suzaku | MLCOLodging | 2022-12-02 | 20 | +26.7% | +$10,479 | $39,180 | 74.0 | MA12_CLOSE |
| Byakko | VTAKHealthcare-Products | 2022-12-29 | 9 | -15.0% | -$1,945 | $12,967 | 50.0 | STOP_LOSS |
| Byakko | CHRSPharmaceuticals | 2023-01-03 | 11 | +12.0% | +$1,723 | $14,324 | 50.0 | TIMED_EXIT |
| Byakko | EQXMining | 2023-01-04 | 11 | +17.3% | +$2,386 | $13,762 | 50.0 | TIMED_EXIT |
| Byakko | GDXDefensive ETF | 2023-01-04 | 15 | +6.0% | +$993 | $16,697 | 0.0 | DAY15_TRIM |
| Byakko | GDXDefensive ETF | 2023-01-04 | 20 | +2.6% | +$648 | $25,014 | 0.0 | GATE_EXIT |
| Byakko | OTLYFood | 2023-01-04 | 11 | +18.6% | +$2,590 | $13,944 | 50.0 | TIMED_EXIT |
| Byakko | NVCRHealthcare-Products | 2023-01-06 | 2 | -8.6% | -$1,101 | $12,785 | 50.0 | STOP_LOSS |
| Byakko | HBMMining | 2023-01-09 | 11 | +1.7% | +$227 | $13,064 | 50.0 | TIMED_EXIT |
| Byakko | STAAHealthcare-Products | 2023-01-09 | 11 | +20.8% | +$2,816 | $13,509 | 50.0 | TIMED_EXIT |
| Suzaku | PACBHealthcare-Products | 2023-01-18 | 1 | -8.8% | -$3,663 | $41,391 | 66.2 | STOP_LOSS |
| Suzaku | AEHRSemiconductors | 2023-01-24 | 15 | +0.8% | +$339 | $42,474 | 72.3 | MA12_CLOSE |
| Suzaku | SITMSemiconductors | 2023-01-24 | 15 | +5.9% | +$1,000 | $16,913 | 69.1 | DAY15_TRIM |
| Suzaku | SITMSemiconductors | 2023-01-24 | 23 | +4.8% | +$1,210 | $25,489 | 69.1 | MA12_CLOSE |
| Suzaku | TGTXBiotechnology | 2023-01-24 | 15 | +31.2% | +$3,658 | $11,732 | 71.6 | DAY15_TRIM |
| Suzaku | TGTXBiotechnology | 2023-01-24 | 24 | +24.4% | +$4,298 | $17,599 | 71.6 | MA12_CLOSE |
| Suzaku | PTONLeisure Time | 2023-01-30 | 11 | +10.4% | +$1,842 | $17,680 | 70.0 | MA12_CLOSE |
| Suzaku | VKTXBiotechnology | 2023-02-09 | 18 | +2.7% | +$1,174 | $43,511 | 66.3 | MA12_CLOSE |
| Suzaku | MNDYSoftware | 2023-02-15 | 2 | -9.0% | -$3,984 | $44,244 | 70.0 | STOP_LOSS |
| Suzaku | FSLYSoftware | 2023-02-17 | 4 | -8.6% | -$3,889 | $45,519 | 71.2 | STOP_LOSS |
| Suzaku | SMGHousewares | 2023-02-17 | 6 | -5.4% | -$2,468 | $45,518 | 67.2 | STOP_LOSS |
| Suzaku | TWLOSoftware | 2023-02-17 | 4 | -6.5% | -$2,958 | $45,486 | 67.0 | STOP_LOSS |
| Suzaku | ACVASoftware | 2023-02-24 | 17 | +1.5% | +$663 | $42,990 | 77.5 | MA12_CLOSE |
| Suzaku | TMDXHealthcare-Products | 2023-02-24 | 13 | -1.9% | -$815 | $42,885 | 72.8 | MA12_CLOSE |
| Suzaku | NTRAHealthcare-Products | 2023-03-03 | 7 | -6.5% | -$2,807 | $43,459 | 68.3 | STOP_LOSS |
| Suzaku | IOTSoftware | 2023-03-06 | 10 | -6.2% | -$2,705 | $43,477 | 67.8 | STOP_LOSS |
| Byakko | CDEMining | 2023-03-28 | 11 | +21.7% | +$2,707 | $12,451 | 50.0 | TIMED_EXIT |
| Byakko | OSCRHealthcare-Services | 2023-03-29 | 11 | +15.6% | +$1,962 | $12,600 | 50.0 | TIMED_EXIT |
| Byakko | KOSOil&Gas | 2023-04-03 | 11 | -6.5% | -$775 | $11,863 | 50.0 | STOP_LOSS |
| Byakko | BFLYHealthcare-Products | 2023-04-10 | 11 | +8.1% | +$1,035 | $12,825 | 50.0 | TIMED_EXIT |
| Byakko | KALAPharmaceuticals | 2023-04-12 | 6 | -14.7% | -$1,823 | $12,432 | 50.0 | STOP_LOSS |
| Seiryū | RIOTInvestment Companies | 2023-04-14 | 3 | -9.3% | -$3,209 | $34,584 | 71.6 | STOP_LOSS |
| Seiryū | VKTXBiotechnology | 2023-04-14 | 12 | +4.0% | +$1,403 | $34,572 | 70.8 | MA12_CLOSE |
| Seiryū | CLSKInvestment Companies | 2023-04-18 | 1 | -10.3% | -$3,477 | $33,639 | 69.9 | STOP_LOSS |
| Seiryū | LEGNBiotechnology | 2023-04-24 | 11 | -1.8% | -$575 | $32,497 | 64.6 | MA12_CLOSE |
| Byakko | NNOXHealthcare-Services | 2023-05-02 | 11 | +71.5% | +$8,782 | $12,283 | 50.0 | TIMED_EXIT |
| Byakko | GDXDefensive ETF | 2023-05-03 | 6 | -3.8% | -$1,596 | $41,518 | 0.0 | GATE_EXIT |
| Byakko | PRVAHealthcare-Services | 2023-05-05 | 7 | -5.7% | -$639 | $11,206 | 50.0 | STOP_LOSS |
| Byakko | ACHPharmaceuticals | 2023-05-08 | 1 | -7.7% | -$871 | $11,384 | 50.0 | STOP_LOSS |
| Byakko | GHHealthcare-Products | 2023-05-11 | 2 | -6.9% | -$778 | $11,252 | 50.0 | STOP_LOSS |
| Seiryū | IONQSoftware | 2023-05-18 | 15 | +1.2% | +$418 | $34,076 | 66.4 | MA12_CLOSE |
| Seiryū | SMCIComputers | 2023-05-18 | 15 | +58.8% | +$8,015 | $13,626 | 67.5 | DAY15_TRIM |
| Seiryū | SMCIComputers | 2023-05-18 | 29 | +39.9% | +$8,161 | $20,431 | 67.5 | MA12_CLOSE |
| Seiryū | IMVTBiotechnology | 2023-05-23 | 1 | -6.2% | -$2,103 | $34,106 | 64.1 | STOP_LOSS |
| Suzaku | SDGRSoftware | 2023-06-16 | 7 | -7.6% | -$3,416 | $44,783 | 78.0 | STOP_LOSS |
| Suzaku | BTBTInvestment Companies | 2023-06-20 | 16 | +7.8% | +$3,623 | $46,235 | 70.9 | MA12_CLOSE |
| Suzaku | KEELInvestment Companies | 2023-06-21 | 15 | +49.1% | +$9,087 | $18,493 | 72.6 | DAY15_TRIM |
| Suzaku | KEELInvestment Companies | 2023-06-21 | 29 | +22.6% | +$6,273 | $27,741 | 72.6 | MA12_CLOSE |
| Suzaku | MARAInvestment Companies | 2023-06-22 | 15 | +52.6% | +$9,726 | $18,497 | 73.1 | DAY15_TRIM |
| Suzaku | MARAInvestment Companies | 2023-06-22 | 29 | +42.4% | +$11,762 | $27,734 | 73.1 | MA12_CLOSE |
| Suzaku | HUTInvestment Companies | 2023-06-23 | 3 | -8.4% | -$3,409 | $40,680 | 68.5 | STOP_LOSS |
| Suzaku | HUTInvestment Companies | 2023-06-28 | 21 | +24.6% | +$9,162 | $37,262 | 68.5 | MA12_CLOSE |
| Suzaku | CLSKInvestment Companies | 2023-07-06 | 15 | +18.9% | +$8,573 | $45,429 | 82.8 | MA12_CLOSE |
| Suzaku | IONQSoftware | 2023-07-19 | 5 | -7.5% | -$3,807 | $50,988 | 80.2 | MA12_CLOSE |
| Suzaku | XPEVAuto Manufacturers | 2023-07-24 | 11 | +14.2% | +$8,254 | $58,126 | 63.5 | MA12_CLOSE |
| Suzaku | NIOAuto Manufacturers | 2023-07-26 | 14 | +2.0% | +$1,161 | $58,111 | 62.4 | MA12_CLOSE |
| Suzaku | WALBanks | 2023-07-27 | 13 | -1.2% | -$700 | $58,079 | 63.6 | MA12_CLOSE |
| Suzaku | SMCIComputers | 2023-07-28 | 12 | -11.5% | -$6,689 | $58,127 | 73.7 | STOP_LOSS |
| Suzaku | SABRLeisure Time | 2023-08-10 | 7 | -8.8% | -$5,146 | $58,626 | 64.3 | STOP_LOSS |
| Byakko | CELHBeverages | 2023-08-30 | 11 | +7.6% | +$1,116 | $14,769 | 50.0 | TIMED_EXIT |
| Byakko | CGCPharmaceuticals | 2023-08-31 | 11 | +184.2% | +$29,304 | $15,908 | 50.0 | TIMED_EXIT |
| Byakko | XOPDefensive ETF | 2023-09-05 | 9 | -1.4% | -$775 | $57,267 | 0.0 | GATE_EXIT |
| Byakko | XOPDefensive ETF | 2023-09-28 | 1 | -1.8% | -$1,131 | $64,732 | 0.0 | GATE_EXIT |
| Byakko | XOPDefensive ETF | 2023-10-17 | 7 | -4.0% | -$2,540 | $64,376 | 0.0 | GATE_EXIT |
| Byakko | BTAIPharmaceuticals | 2023-10-31 | 11 | -13.7% | -$2,074 | $15,116 | 50.0 | STOP_LOSS |
| Byakko | SPRCPharmaceuticals | 2023-11-01 | 8 | -15.0% | -$2,032 | $13,548 | 50.0 | STOP_LOSS |
| Seiryū | MSTRSoftware | 2023-11-10 | 4 | -6.5% | -$3,264 | $50,614 | 63.2 | STOP_LOSS |
| Seiryū | DUOLSoftware | 2023-11-14 | 1 | -6.5% | -$3,204 | $49,394 | 65.8 | STOP_LOSS |
| Seiryū | PISemiconductors | 2023-11-15 | 20 | +4.8% | +$2,360 | $48,877 | 64.9 | MA12_CLOSE |
| Seiryū | CRSPBiotechnology | 2023-11-20 | 10 | -7.5% | -$3,677 | $48,915 | 67.8 | STOP_LOSS |
| Seiryū | COINDiversified Finan Serv | 2023-11-21 | 15 | +42.5% | +$8,309 | $19,535 | 65.1 | DAY15_TRIM |
| Seiryū | COINDiversified Finan Serv | 2023-11-21 | 42 | +48.4% | +$14,203 | $29,356 | 65.1 | MA12_CLOSE |
| Suzaku | BKKTDiversified Finan Serv | 2023-12-28 | 6 | -18.5% | -$11,622 | $62,809 | 83.0 | STOP_LOSS |
| Suzaku | GCTSoftware | 2023-12-28 | 15 | +11.5% | +$7,237 | $62,937 | 74.1 | MA12_CLOSE |
| Suzaku | METCCoal | 2024-01-04 | 12 | -6.7% | -$4,203 | $62,508 | 72.4 | STOP_LOSS |
| Suzaku | KROSBiotechnology | 2024-01-05 | 15 | +21.0% | +$5,242 | $24,987 | 67.9 | DAY15_TRIM |
| Suzaku | KROSBiotechnology | 2024-01-05 | 28 | +9.8% | +$3,677 | $37,529 | 67.9 | MA12_CLOSE |
| Suzaku | RXRXBiotechnology | 2024-01-05 | 6 | -8.6% | -$5,402 | $62,623 | 65.8 | STOP_LOSS |
| Suzaku | SANABiotechnology | 2024-01-11 | 7 | -12.1% | -$6,942 | $57,234 | 72.4 | STOP_LOSS |
| Suzaku | LQDABiotechnology | 2024-01-18 | 5 | -6.4% | -$3,903 | $60,851 | 69.2 | STOP_LOSS |
| Suzaku | EWTXBiotechnology | 2024-01-23 | 15 | +22.2% | +$5,288 | $23,832 | 78.0 | DAY15_TRIM |
| Suzaku | EWTXBiotechnology | 2024-01-23 | 22 | +15.8% | +$5,650 | $35,733 | 78.0 | MA12_CLOSE |
| Suzaku | SMCIComputers | 2024-01-23 | 15 | +72.9% | +$17,349 | $23,809 | 66.7 | DAY15_TRIM |
| Suzaku | SMCIComputers | 2024-01-23 | 29 | +60.2% | +$21,497 | $35,713 | 66.7 | MA12_CLOSE |
| Suzaku | ARQTBiotechnology | 2024-01-24 | 15 | +66.1% | +$15,736 | $23,818 | 73.1 | DAY15_TRIM |
| Suzaku | ARQTBiotechnology | 2024-01-24 | 47 | +119.7% | +$42,781 | $35,731 | 73.1 | MA12_CLOSE |
| Suzaku | EYPTBiotechnology | 2024-02-02 | 3 | -8.5% | -$5,328 | $62,514 | 74.4 | STOP_LOSS |
| Suzaku | MGNXBiotechnology | 2024-02-05 | 15 | +2.3% | +$1,409 | $61,182 | 71.8 | MA12_CLOSE |
| Suzaku | VKTXBiotechnology | 2024-02-14 | 15 | +129.4% | +$37,347 | $28,875 | 72.5 | DAY15_TRIM |
| Suzaku | VKTXBiotechnology | 2024-02-14 | 23 | +122.3% | +$52,944 | $43,296 | 72.5 | MA12_CLOSE |
| Suzaku | RGTIComputers | 2024-02-20 | 1 | -11.5% | -$8,309 | $72,542 | 79.6 | STOP_LOSS |
| Suzaku | IOVABiotechnology | 2024-02-22 | 15 | -1.7% | -$1,291 | $75,839 | 73.2 | MA12_CLOSE |
| Suzaku | CCCCBiotechnology | 2024-02-23 | 20 | +5.6% | +$4,226 | $75,834 | 73.3 | MA12_CLOSE |
| Suzaku | MRNABiotechnology | 2024-03-12 | 2 | -5.8% | -$6,314 | $108,772 | 67.4 | STOP_LOSS |
| Suzaku | IBRXBiotechnology | 2024-03-21 | 4 | -9.8% | -$10,583 | $108,262 | 71.9 | STOP_LOSS |
| Suzaku | MODBuilding Materials | 2024-03-21 | 4 | -5.5% | -$5,974 | $108,046 | 64.3 | STOP_LOSS |
| Suzaku | NUVBBiotechnology | 2024-03-28 | 8 | -10.2% | -$10,645 | $104,124 | 79.8 | STOP_LOSS |
| Suzaku | SNDLFood | 2024-03-28 | 13 | +3.0% | +$3,161 | $104,123 | 66.8 | MA12_CLOSE |
| Suzaku | STOKBiotechnology | 2024-03-28 | 7 | -12.9% | -$13,386 | $104,094 | 80.7 | STOP_LOSS |
| Suzaku | OUSTSemiconductors | 2024-04-02 | 7 | -8.3% | -$8,604 | $104,121 | 72.4 | STOP_LOSS |
| Suzaku | EXKMining | 2024-04-04 | 11 | -1.3% | -$1,187 | $90,719 | 66.7 | MA12_CLOSE |
| Suzaku | SMTCSemiconductors | 2024-04-05 | 13 | -1.7% | -$1,592 | $93,483 | 65.8 | MA12_CLOSE |
| Suzaku | ARQTBiotechnology | 2024-04-09 | 3 | -9.3% | -$8,838 | $95,507 | 70.4 | STOP_LOSS |
| Suzaku | JANXBiotechnology | 2024-04-10 | 14 | +7.8% | +$7,575 | $96,744 | 66.6 | MA12_CLOSE |
| Suzaku | GERNBiotechnology | 2024-04-12 | 11 | -4.0% | -$3,503 | $86,740 | 74.0 | MA12_CLOSE |
| Suzaku | SMTCSemiconductors | 2024-04-29 | 15 | +8.4% | +$3,194 | $37,940 | 70.6 | DAY15_TRIM |
| Suzaku | SMTCSemiconductors | 2024-04-29 | 24 | +6.1% | +$3,457 | $56,892 | 70.6 | MA12_CLOSE |
| Suzaku | IESCEngineering&Construction | 2024-05-06 | 8 | -6.2% | -$5,826 | $94,808 | 74.2 | STOP_LOSS |
| Suzaku | VSTElectric | 2024-05-09 | 5 | -5.7% | -$5,362 | $94,849 | 69.9 | STOP_LOSS |
| Suzaku | EXKMining | 2024-05-15 | 20 | +4.1% | +$3,655 | $89,370 | 68.8 | MA12_CLOSE |
| Suzaku | AGMining | 2024-05-20 | 2 | -6.3% | -$5,711 | $90,128 | 77.2 | STOP_LOSS |
| Suzaku | WULFInvestment Companies | 2024-06-12 | 15 | +45.2% | +$16,842 | $37,289 | 75.6 | DAY15_TRIM |
| Suzaku | WULFInvestment Companies | 2024-06-12 | 28 | +26.8% | +$15,006 | $55,932 | 75.6 | MA12_CLOSE |
| Suzaku | HUTInvestment Companies | 2024-06-13 | 15 | +51.7% | +$19,279 | $37,284 | 75.2 | DAY15_TRIM |
| Suzaku | HUTInvestment Companies | 2024-06-13 | 27 | +32.1% | +$17,973 | $55,914 | 75.2 | MA12_CLOSE |
| Suzaku | BTBTInvestment Companies | 2024-07-08 | 2 | -10.8% | -$11,088 | $102,250 | 67.5 | STOP_LOSS |
| Suzaku | AEHRSemiconductors | 2024-07-11 | 21 | +9.3% | +$10,029 | $107,706 | 64.2 | MA12_CLOSE |
| Suzaku | ASTSTelecommunications | 2024-07-15 | 15 | +37.8% | +$16,272 | $43,085 | 72.4 | DAY15_TRIM |
| Suzaku | ASTSTelecommunications | 2024-07-15 | 44 | +106.3% | +$68,719 | $64,620 | 72.4 | MA12_CLOSE |
| Suzaku | CORZInvestment Companies | 2024-07-15 | 3 | -7.9% | -$8,514 | $107,708 | 72.9 | MA12_CLOSE |
| Suzaku | HUTInvestment Companies | 2024-07-15 | 3 | -10.4% | -$11,239 | $107,708 | 70.7 | STOP_LOSS |
| Genbu | ASTSTelecommunications | 2024-07-25 | 15 | +88.3% | +$33,459 | $37,911 | 67.7 | DAY15_TRIM |
| Genbu | ASTSTelecommunications | 2024-07-25 | 34 | +67.1% | +$38,181 | $56,849 | 67.7 | MA12_CLOSE |
| Genbu | LUMNTelecommunications | 2024-07-26 | 15 | +239.8% | +$90,955 | $37,934 | 64.5 | DAY15_TRIM |
| Genbu | LUMNTelecommunications | 2024-07-26 | 32 | +194.8% | +$110,893 | $56,900 | 64.5 | MA12_CLOSE |
| Genbu | SMMTBiotechnology | 2024-07-29 | 4 | -8.4% | -$514 | $6,140 | 69.7 | STOP_LOSS |
| Genbu | CDNAHealthcare-Products | 2024-08-02 | 3 | -11.3% | -$8,777 | $78,122 | 64.1 | STOP_LOSS |
| Genbu | ZETASoftware | 2024-08-02 | 3 | -13.1% | -$5,937 | $45,237 | 62.8 | STOP_LOSS |
| Genbu | OMCLHealthcare-Products | 2024-08-06 | 1 | -6.5% | -$4,895 | $75,705 | 61.7 | STOP_LOSS |
| Genbu | VXX | 2024-08-06 | 1 | -13.0% | -$9,713 | $74,702 | 62.5 | STOP_LOSS |
| Suzaku | GDSTelecommunications | 2024-08-23 | 18 | +1.1% | +$1,438 | $128,892 | 70.8 | MA12_CLOSE |
| Suzaku | HOVHome Builders | 2024-08-23 | 5 | -6.3% | -$8,098 | $128,283 | 76.8 | STOP_LOSS |
| Suzaku | PSNYAuto Manufacturers | 2024-09-03 | 1 | -11.4% | -$21,115 | $185,425 | 74.0 | STOP_LOSS |
| Suzaku | GGALBanks | 2024-09-05 | 19 | +5.4% | +$9,766 | $180,140 | 65.1 | MA12_CLOSE |
| Suzaku | VISNTelecommunications | 2024-09-12 | 19 | +15.7% | +$26,963 | $172,082 | 79.5 | MA12_CLOSE |
| Suzaku | TLNElectric | 2024-09-13 | 19 | +5.3% | +$9,094 | $171,757 | 71.6 | MA12_CLOSE |
| Suzaku | MPTREITs | 2024-09-16 | 2 | -6.8% | -$11,717 | $172,283 | 70.2 | STOP_LOSS |
| Suzaku | FLGBanks | 2024-09-18 | 5 | -6.7% | -$10,711 | $160,556 | 65.1 | STOP_LOSS |
| Suzaku | LUMNTelecommunications | 2024-09-23 | 8 | -9.9% | -$14,829 | $149,863 | 74.2 | STOP_LOSS |
| Suzaku | GDSTelecommunications | 2024-09-24 | 1 | -8.7% | -$15,479 | $177,326 | 69.8 | STOP_LOSS |
| Suzaku | RKLBAerospace/Defense | 2024-09-26 | 14 | +7.8% | +$13,599 | $173,469 | 71.6 | MA12_CLOSE |
| Suzaku | LXDiversified Finan Serv | 2024-10-02 | 1 | -6.4% | -$11,032 | $172,218 | 68.0 | STOP_LOSS |
| Suzaku | UNFIFood | 2024-10-02 | 1 | -5.9% | -$10,088 | $172,137 | 68.2 | STOP_LOSS |
| Suzaku | RKLBAerospace/Defense | 2024-10-16 | 14 | -2.3% | -$3,982 | $176,900 | 70.0 | MA12_CLOSE |
| Suzaku | LEUMining | 2024-10-17 | 18 | -4.0% | -$6,993 | $176,785 | 70.5 | MA12_CLOSE |
| Genbu | PCTEnvironmental Control | 2024-10-24 | 7 | -7.9% | -$13,299 | $168,365 | 63.0 | STOP_LOSS |
| Genbu | MSTRSoftware | 2024-10-25 | 7 | -2.2% | -$3,087 | $142,152 | 67.4 | MA12_CLOSE |
| Genbu | LACMining | 2024-10-28 | 9 | -9.3% | -$4,043 | $43,410 | 67.9 | STOP_LOSS |
| Genbu | LEUMining | 2024-11-01 | 3 | -14.8% | -$20,989 | $141,764 | 70.8 | STOP_LOSS |
| Genbu | LMNDInsurance | 2024-11-01 | 15 | +103.8% | +$59,812 | $57,583 | 61.8 | DAY15_TRIM |
| Genbu | LMNDInsurance | 2024-11-01 | 32 | +86.3% | +$74,548 | $86,398 | 61.8 | MA12_CLOSE |
| Suzaku | HUTInvestment Companies | 2024-11-06 | 20 | +31.1% | +$50,937 | $163,793 | 64.1 | MA12_CLOSE |
| Suzaku | LMNDInsurance | 2024-11-06 | 1 | -6.7% | -$10,978 | $163,748 | 66.1 | STOP_LOSS |
| Suzaku | RKLBAerospace/Defense | 2024-11-06 | 15 | +96.5% | +$63,221 | $65,511 | 69.0 | DAY15_TRIM |
| Suzaku | RKLBAerospace/Defense | 2024-11-06 | 28 | +76.7% | +$75,401 | $98,260 | 69.0 | MA12_CLOSE |
| Suzaku | KCSoftware | 2024-11-07 | 5 | -8.4% | -$13,243 | $158,314 | 72.0 | STOP_LOSS |
| Suzaku | POWLElectrical Compo&Equip | 2024-11-07 | 6 | -6.3% | -$894 | $14,304 | 76.9 | STOP_LOSS |
| Suzaku | DAVEDiversified Finan Serv | 2024-11-12 | 15 | +39.6% | +$22,957 | $58,022 | 74.0 | DAY15_TRIM |
| Suzaku | DAVEDiversified Finan Serv | 2024-11-12 | 27 | +33.9% | +$29,542 | $87,065 | 74.0 | MA12_CLOSE |
| Suzaku | LUNRAerospace/Defense | 2024-11-13 | 1 | -8.9% | -$1,201 | $13,467 | 70.1 | STOP_LOSS |
| Suzaku | JOBYAerospace/Defense | 2024-11-22 | 19 | +11.8% | +$15,256 | $129,671 | 73.9 | MA12_CLOSE |
| Suzaku | RGTIComputers | 2024-11-26 | 15 | +385.4% | +$285,078 | $73,965 | 84.6 | DAY15_TRIM |
| Suzaku | RGTIComputers | 2024-11-26 | 43 | +355.4% | +$394,364 | $110,947 | 84.6 | MA12_CLOSE |
| Genbu | CRDOTelecommunications | 2024-12-16 | 1 | -8.3% | -$21,272 | $255,103 | 69.5 | STOP_LOSS |
| Genbu | GRRRComputers | 2024-12-16 | 22 | +84.6% | +$215,841 | $255,138 | 70.7 | MA12_CLOSE |
| Genbu | IONQSoftware | 2024-12-17 | 1 | -12.9% | -$31,952 | $248,295 | 73.7 | STOP_LOSS |
| Byakko | GDXDefensive ETF | 2025-03-06 | 2 | -2.1% | -$9,569 | $465,631 | 0.0 | GATE_EXIT |
| Byakko | EXKMining | 2025-03-12 | 11 | -2.4% | -$2,925 | $120,187 | 50.0 | TIMED_EXIT |
| Byakko | GDXDefensive ETF | 2025-03-12 | 15 | +9.2% | +$17,070 | $185,282 | 0.0 | DAY15_TRIM |
| Byakko | GDXDefensive ETF | 2025-03-12 | 17 | -0.5% | -$1,459 | $277,965 | 0.0 | GATE_EXIT |
| Byakko | LFWDHealthcare-Products | 2025-03-20 | 11 | -11.6% | -$15,027 | $129,517 | 50.0 | TIMED_EXIT |
| Byakko | NAKAHealthcare-Services | 2025-03-25 | 5 | -15.0% | -$17,307 | $115,379 | 50.0 | STOP_LOSS |
| Byakko | RYTMPharmaceuticals | 2025-04-08 | 2 | -7.7% | -$8,700 | $113,782 | 50.0 | STOP_LOSS |
| Byakko | GDXDefensive ETF | 2025-04-10 | 14 | +0.1% | +$290 | $456,134 | 0.0 | GATE_EXIT |
| Byakko | IAGMining | 2025-04-10 | 11 | +5.9% | +$7,168 | $122,037 | 50.0 | TIMED_EXIT |
| Byakko | SBSWMining | 2025-04-14 | 11 | +6.0% | +$7,057 | $116,719 | 50.0 | TIMED_EXIT |
| Byakko | XLEDefensive ETF | 2025-04-14 | 15 | +1.7% | +$3,111 | $182,487 | 0.0 | DAY15_TRIM |
| Byakko | XLEDefensive ETF | 2025-04-14 | 53 | +7.9% | +$21,746 | $273,691 | 0.0 | GATE_EXIT |
| Byakko | USARMining | 2025-04-15 | 4 | -15.0% | -$17,640 | $117,600 | 50.0 | STOP_LOSS |
| Byakko | UUUUMining | 2025-04-17 | 2 | -8.1% | -$10,207 | $125,863 | 50.0 | STOP_LOSS |
| Byakko | QUREPharmaceuticals | 2025-04-21 | 11 | +22.8% | +$26,467 | $116,098 | 50.0 | TIMED_EXIT |
| Byakko | NGMining | 2025-04-22 | 11 | +23.8% | +$28,672 | $120,353 | 50.0 | TIMED_EXIT |
| Byakko | CGCPharmaceuticals | 2025-04-24 | 11 | +8.1% | +$9,871 | $122,397 | 50.0 | TIMED_EXIT |
| Byakko | CORTPharmaceuticals | 2025-04-24 | 11 | +3.1% | +$3,657 | $117,189 | 50.0 | TIMED_EXIT |
| Byakko | GRALHealthcare-Products | 2025-04-24 | 11 | +4.8% | +$6,451 | $133,834 | 50.0 | TIMED_EXIT |
| Byakko | USARMining | 2025-04-24 | 6 | -15.0% | -$5,389 | $35,925 | 50.0 | STOP_LOSS |
| Byakko | INDVPharmaceuticals | 2025-04-25 | 11 | +3.0% | +$3,580 | $120,394 | 50.0 | TIMED_EXIT |
| Byakko | TEMHealthcare-Products | 2025-04-25 | 11 | +15.3% | +$1,346 | $8,780 | 50.0 | TIMED_EXIT |
| Seiryū | ODDCosmetics/Personal Care | 2025-05-05 | 8 | -7.4% | -$26,920 | $365,650 | 63.6 | STOP_LOSS |
| Seiryū | DUOLSoftware | 2025-05-09 | 12 | +0.1% | +$379 | $372,115 | 63.0 | MA12_CLOSE |
| Seiryū | DAVEDiversified Finan Serv | 2025-05-12 | 15 | +22.2% | +$33,549 | $151,097 | 63.2 | DAY15_TRIM |
| Seiryū | DAVEDiversified Finan Serv | 2025-05-12 | 32 | +20.9% | +$47,311 | $226,473 | 63.2 | MA12_CLOSE |
| Seiryū | TMDXHealthcare-Products | 2025-05-12 | 21 | +4.2% | +$15,866 | $379,603 | 62.7 | MA12_CLOSE |
| Seiryū | QBTSComputers | 2025-05-16 | 20 | +34.2% | +$125,013 | $365,746 | 66.5 | MA12_CLOSE |
| Seiryū | QUBTSoftware | 2025-05-19 | 2 | -9.3% | -$8,737 | $93,491 | 67.8 | STOP_LOSS |
| Seiryū | QUBTSoftware | 2025-05-23 | 7 | -11.9% | -$11,925 | $99,885 | 65.2 | STOP_LOSS |
| Seiryū | RGTIComputers | 2025-05-23 | 7 | -11.4% | -$40,728 | $357,362 | 67.5 | STOP_LOSS |
| Seiryū | ELFCosmetics/Personal Care | 2025-05-30 | 21 | +6.3% | +$5,353 | $84,564 | 64.7 | MA12_CLOSE |
| Seiryū | ODDCosmetics/Personal Care | 2025-05-30 | 10 | -6.0% | -$19,308 | $319,997 | 65.6 | STOP_LOSS |
| Seiryū | OUSTSemiconductors | 2025-06-02 | 15 | +87.3% | +$138,115 | $158,204 | 64.3 | DAY15_TRIM |
| Seiryū | OUSTSemiconductors | 2025-06-02 | 29 | +68.8% | +$163,398 | $237,300 | 64.3 | MA12_CLOSE |
| Seiryū | TSSIEngineering&Construction | 2025-06-05 | 15 | +78.4% | +$154,875 | $197,565 | 73.6 | DAY15_TRIM |
| Seiryū | TSSIEngineering&Construction | 2025-06-05 | 33 | +57.5% | +$170,503 | $296,339 | 73.6 | MA12_CLOSE |
| Suzaku | ATAIBiotechnology | 2025-08-25 | 10 | -9.5% | -$63,159 | $664,406 | 75.8 | STOP_LOSS |
| Suzaku | IRENInvestment Companies | 2025-08-25 | 15 | +57.5% | +$152,806 | $265,752 | 75.4 | DAY15_TRIM |
| Suzaku | IRENInvestment Companies | 2025-08-25 | 56 | +155.6% | +$620,397 | $398,640 | 75.4 | MA12_CLOSE |
| Suzaku | TIGRDiversified Finan Serv | 2025-08-25 | 2 | -6.5% | -$43,140 | $664,393 | 72.8 | STOP_LOSS |
| Suzaku | UUUUMining | 2025-08-25 | 15 | +22.6% | +$59,973 | $265,755 | 73.1 | DAY15_TRIM |
| Suzaku | UUUUMining | 2025-08-25 | 36 | +40.2% | +$160,083 | $398,622 | 73.1 | MA12_CLOSE |
| Suzaku | CIFRInvestment Companies | 2025-08-27 | 15 | +69.4% | +$172,360 | $248,505 | 75.7 | DAY15_TRIM |
| Suzaku | CIFRInvestment Companies | 2025-08-27 | 29 | +66.5% | +$247,796 | $372,758 | 75.7 | MA12_CLOSE |
| Suzaku | TVTXBiotechnology | 2025-09-05 | 15 | +16.8% | +$40,395 | $240,488 | 72.1 | DAY15_TRIM |
| Suzaku | TVTXBiotechnology | 2025-09-05 | 24 | +10.9% | +$39,208 | $360,753 | 72.1 | MA12_CLOSE |
| Genbu | METCCoal | 2025-09-25 | 15 | +49.9% | +$113,576 | $227,691 | 69.2 | DAY15_TRIM |
| Genbu | METCCoal | 2025-09-25 | 26 | +26.2% | +$89,649 | $341,552 | 69.2 | MA12_CLOSE |
| Genbu | ASMMining | 2025-09-29 | 3 | -6.7% | -$48,238 | $719,094 | 72.2 | STOP_LOSS |
| Genbu | CDEMining | 2025-09-29 | 15 | +17.5% | +$50,328 | $287,568 | 73.3 | DAY15_TRIM |
| Genbu | CDEMining | 2025-09-29 | 22 | -1.5% | -$6,608 | $431,352 | 73.3 | MA12_CLOSE |
| Genbu | HIVEInvestment Companies | 2025-10-02 | 14 | +33.7% | +$237,208 | $704,355 | 69.5 | MA12_CLOSE |
| Suzaku | SUPXComputers | 2025-10-06 | 1 | -13.3% | -$112,621 | $843,897 | 80.2 | STOP_LOSS |
| Suzaku | BZAISemiconductors | 2025-10-07 | 6 | -10.2% | -$75,409 | $742,960 | 76.2 | STOP_LOSS |
| Suzaku | WULFInvestment Companies | 2025-10-10 | 11 | -2.9% | -$3,783 | $128,987 | 76.4 | MA12_CLOSE |
| Suzaku | MLYSBiotechnology | 2025-10-13 | 10 | -5.4% | -$35,999 | $667,554 | 76.8 | MA12_CLOSE |
| Suzaku | NUVBBiotechnology | 2025-10-22 | 16 | +13.8% | +$147,396 | $1,072,115 | 74.2 | MA12_CLOSE |
| Suzaku | LDIDiversified Finan Serv | 2025-10-24 | 5 | -11.4% | -$115,721 | $1,012,110 | 76.3 | STOP_LOSS |
| Suzaku | LUMNTelecommunications | 2025-10-24 | 18 | +14.1% | +$142,807 | $1,012,083 | 77.1 | MA12_CLOSE |
| Suzaku | AXTISemiconductors | 2025-10-27 | 15 | +65.4% | +$264,868 | $404,847 | 84.2 | DAY15_TRIM |
| Suzaku | AXTISemiconductors | 2025-10-27 | 24 | +52.4% | +$317,970 | $607,270 | 84.2 | MA12_CLOSE |
| Suzaku | INTCSemiconductors | 2025-10-29 | 6 | -7.9% | -$71,034 | $896,320 | 74.5 | STOP_LOSS |
| Suzaku | PRLDBiotechnology | 2025-11-04 | 1 | -11.1% | -$91,955 | $825,351 | 77.4 | STOP_LOSS |
| Suzaku | CTMXBiotechnology | 2025-11-05 | 2 | -9.9% | -$72,745 | $733,382 | 68.3 | STOP_LOSS |
| Suzaku | SITMSemiconductors | 2025-11-07 | 6 | -8.2% | -$82,828 | $1,011,909 | 74.7 | STOP_LOSS |
| Suzaku | VRDNBiotechnology | 2025-11-07 | 15 | +14.5% | +$58,698 | $404,843 | 73.1 | DAY15_TRIM |
| Suzaku | VRDNBiotechnology | 2025-11-07 | 41 | +14.9% | +$90,665 | $607,250 | 73.1 | MA12_CLOSE |
| Suzaku | SKYTSemiconductors | 2025-11-11 | 2 | -11.1% | -$115,891 | $1,047,804 | 80.4 | STOP_LOSS |
| Suzaku | CELCBiotechnology | 2025-11-13 | 15 | +22.7% | +$89,027 | $392,122 | 73.5 | DAY15_TRIM |
| Suzaku | CELCBiotechnology | 2025-11-13 | 28 | +16.9% | +$99,644 | $588,226 | 73.5 | MA12_CLOSE |
| Suzaku | APGEBiotechnology | 2025-11-14 | 15 | +16.1% | +$62,949 | $392,147 | 67.0 | DAY15_TRIM |
| Suzaku | APGEBiotechnology | 2025-11-14 | 45 | +16.4% | +$96,340 | $588,254 | 67.0 | MA12_CLOSE |
| Suzaku | HYMCMining | 2025-12-15 | 15 | +127.3% | +$622,023 | $488,561 | 72.6 | DAY15_TRIM |
| Suzaku | HYMCMining | 2025-12-15 | 46 | +185.2% | +$1,357,215 | $732,848 | 72.6 | MA12_CLOSE |
| Suzaku | NUVBBiotechnology | 2025-12-18 | 12 | -0.8% | -$9,391 | $1,244,074 | 74.2 | MA12_CLOSE |
| Suzaku | IVVDBiotechnology | 2025-12-23 | 7 | -10.2% | -$126,992 | $1,244,079 | 82.9 | STOP_LOSS |
| Suzaku | SGMLMining | 2026-01-06 | 2 | -10.8% | -$132,158 | $1,229,563 | 75.2 | STOP_LOSS |
| Suzaku | HLMining | 2026-01-07 | 21 | +27.0% | +$373,545 | $1,384,514 | 80.1 | MA12_CLOSE |
| Suzaku | SKYTSemiconductors | 2026-01-07 | 15 | +17.4% | +$96,061 | $553,812 | 76.7 | DAY15_TRIM |
| Suzaku | SKYTSemiconductors | 2026-01-07 | 23 | +12.6% | +$104,707 | $830,732 | 76.7 | MA12_CLOSE |
| Suzaku | ACMRSemiconductors | 2026-02-02 | 2 | -6.8% | -$124,194 | $1,839,410 | 75.0 | STOP_LOSS |
| Suzaku | ALMMining | 2026-02-06 | 6 | -9.7% | -$174,632 | $1,808,313 | 67.6 | STOP_LOSS |
| Suzaku | FORMSemiconductors | 2026-02-06 | 15 | +10.3% | +$74,584 | $723,313 | 62.2 | DAY15_TRIM |
| Suzaku | FORMSemiconductors | 2026-02-06 | 25 | +2.5% | +$27,693 | $1,084,925 | 62.2 | MA12_CLOSE |
| Suzaku | TERSemiconductors | 2026-02-09 | 18 | +3.0% | +$54,697 | $1,807,614 | 68.8 | MA12_CLOSE |
| Suzaku | UCTTSemiconductors | 2026-02-09 | 22 | +17.1% | +$309,853 | $1,808,356 | 70.3 | MA12_CLOSE |
| Suzaku | LSCCSemiconductors | 2026-02-12 | 7 | -6.1% | -$99,593 | $1,634,161 | 75.3 | STOP_LOSS |
| Suzaku | AXTISemiconductors | 2026-02-24 | 10 | -7.9% | -$121,383 | $1,534,634 | 80.7 | MA12_CLOSE |
| Suzaku | ISSCAerospace/Defense | 2026-03-05 | 1 | -7.8% | -$145,097 | $1,856,495 | 73.5 | STOP_LOSS |
| Byakko | PROPOil&Gas | 2026-03-27 | 3 | -12.9% | -$56,506 | $437,505 | 50.0 | STOP_LOSS |
| Byakko | CENXMining | 2026-03-31 | 11 | +15.9% | +$67,531 | $424,295 | 50.0 | TIMED_EXIT |
| Byakko | AUGOMining | 2026-04-01 | 11 | +25.1% | +$116,033 | $463,144 | 50.0 | TIMED_EXIT |
| Byakko | SSRMMining | 2026-04-01 | 11 | +3.3% | +$14,547 | $447,843 | 50.0 | TIMED_EXIT |
| Byakko | SGMLMining | 2026-04-06 | 11 | +50.9% | +$211,058 | $414,330 | 50.0 | TIMED_EXIT |
| Suzaku | VIAVTelecommunications | 2026-04-24 | 4 | -9.5% | -$178,422 | $1,878,021 | 72.8 | STOP_LOSS |
| Suzaku | NOKTelecommunications | 2026-04-30 | 7 | -6.0% | -$109,216 | $1,833,451 | 70.1 | STOP_LOSS |
| Suzaku | POWLElectrical Compo&Equip | 2026-05-01 | 13 | +7.7% | +$140,209 | $1,833,327 | 71.5 | END_OF_BACKTEST |
| Suzaku | CIENTelecommunications | 2026-05-04 | 10 | +9.6% | +$176,614 | $1,833,304 | 76.8 | END_OF_BACKTEST |
Straight answers
Is the Shishin track record live or backtested?
This page is the backtest of the live four-engine stack over 2021-05-12 to 2026-05-14 (1,258 US trading days). The figures are hypothetical, net of fees, on a survivorship-bias-free database. The live, publicly paper-traded NAV, running the same locked strategy, is on the dashboard. Past performance does not predict future results.
Can I independently verify Shishin's track record?
Yes. This page is the backtest, which is a hypothesis. The live, paper-traded forward record is published as a tamper-evident, timestamped log: each day's signals and NAV are committed as a SHA-256 hash, chained to the previous day and anchored to the Bitcoin blockchain via OpenTimestamps, in a public repository. Anyone can recompute the hash from the later-revealed data and confirm it was not altered after the fact. The record is falsifiable and independently checkable at /verify, not self-asserted.
Is Shishin legit?
Shishin is a real, non-advisory research publisher, not a tip service. Instead of asking you to trust a claimed return, it shows the whole record: a survivorship-bias-free five-year backtest with a full statistical battery and every trade on this page, a live paper-traded forward test on the dashboard, and an independently verifiable, timestamped attestation of every published signal at /verify. Weigh the evidence here, then check it yourself.
Is the Sharpe ratio statistically significant, or just data-mined?
The daily returns produce a t-statistic of 5.45, which clears the |t| > 3.0 bar Harvey, Liu and Zhu (2016) propose for a genuine finding after accounting for multiple testing. The Probabilistic Sharpe Ratio (probability the true Sharpe exceeds zero) is > 99.9%. And the Deflated Sharpe Ratio, which penalises for the 242 distinct configurations explored during research, is still > 99.9%: the realised Sharpe of 2.44 far exceeds the 0.756 you would expect as the best of that many random trials.
How is survivorship bias handled?
The historical database is seeded from a full point-in-time universe that includes names later delisted, acquired or bankrupted, not just the survivors visible today. A strategy tested only on companies that made it to the present is flattered by definition; ours is not.
What was the worst drawdown?
15.9% peak-to-trough (2024-03-13 to 2024-05-22), recovered in 58 trading days. A Monte-Carlo block-bootstrap of the daily returns shows that is not a lucky low: 66.8% of 5,000 resampled return-paths drew down deeper, with a median worst drawdown of 18%. One caveat in fairness: reshuffling return blocks breaks the stop-loss sequencing that contained the real drawdowns, so the bootstrap over-states plausible drawdown, read it as a sanity check that the realised low isn't a fluke, not proof the live path stays this shallow.
What is the win rate, and why is it under 50%?
54.8% of the 403 trades were winners. The edge is not hit-rate, it is payoff asymmetry: the average winner returned +31.1% against an average loser of -8.32%, a profit factor of 3.47. Stops cut losers quickly while trend and timed exits let winners run, the signature of a momentum system.
Does this backtest include the ETF sleeve or the capital-efficiency layer?
No. This is the four-engine stack exactly as traded live, position cap at 25% of NAV (a four-position floor), 20 concurrent slots, no top-up, no sleeve. An idle-cash ETF rotation sleeve is validated in research as a future improvement (still in paper-observation, not live-trading) and is written up in the research library; it is deliberately kept off this live record.
Did a handful of trades make the whole result?
The dollars are concentrated: the top 5 trades are ~45% of all gains and the top 10 ~64%, what a compounding momentum book that sizes up as it grows looks like. But the edge is broad, not those trades. Delete the 10 biggest winners outright and the remaining 393 trades still average +10.0% at a per-trade t-stat of 6.6, above the |t| > 3 bar; removing just the top 3 even raises it (6.50 → 6.23), because the moonshots are upside variance, not the source of the significance. They dominate the dollars through compounding, they are not what makes the average trade profitable.
Figures come from one locked, deterministic backtest of the four-engine stack: daily-bar resolution, market-on-close fills, ATR-based stops, breadth-regime engine routing, a day-15 40% partial trim, a 25% position cap and 20 concurrent slots, the live configuration. The regime classifier is computed strictly point-in-time, each session’s regime uses only data through that day’s close, the same function the live bot runs, so there is no look-ahead. Live, entries are placed as market-on-close orders on high-volume names, the closing auction fills the full intended size and sizing against the closing print keeps the book from over-committing capital it doesn’t have. The database is survivorship-bias-free (seeded with delisted and acquired names, not just today’s survivors). The same series feeds the homepage curve and the headline figures across the site, so the numbers never diverge.
What this excludes: one capital-efficiency improvement still in research, an idle-cash ETF rotation sleeve that puts the cash the book holds between regimes to work. It is validated in backtest but kept in paper-observation, not live, so it stays off this live record and is written up in the research library instead. A backtest is a hypothesis about the future, not a promise; past performance does not predict future results, and the live, paper-traded NAV on the dashboard is the honest ongoing test.